Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 3.17225 | 48 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 3.17053 | 49 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 3.16632 | 49 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 3.06781 | 48 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 3.12127 | 49 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 3.279 | 49 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 3.16234 | 46 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 3.15063 | 49 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 3.15525 | 49 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 3.16493 | 50 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 3.21326 | 51 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 3.15097 | 50 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 3.17087 | 49 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 3.11099 | 47 |